Share on StockTwits

Cardiome Pharma Corp (NASDAQ:CRME) announced its earnings results on Monday. The company reported ($0.26) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.16) by $0.10, Analyst Ratings Network reports.

Cardiome Pharma Corp (NASDAQ:CRME) traded up 5.31% during mid-day trading on Monday, hitting $7.53. 50,647 shares of the company’s stock traded hands. Cardiome Pharma Corp has a one year low of $1.90 and a one year high of $11.00. The stock’s 50-day moving average is $7.23 and its 200-day moving average is $7.73. The company’s market cap is $124.4 million.

On the ratings front, analysts at Mackie initiated coverage on shares of Cardiome Pharma Corp in a research note on Tuesday, June 17th. They set a “speculative buy” rating and a $9.50 price target on the stock.

Cardiome Pharma Corp. (NASDAQ:CRME) is a research-based biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.